Factory Making Illegal Oxytocin Injections Busted In Delhi, Owner Arrested

New Delhi: After the directives from the Delhi High Court to combat the use of spurious oxytocin in dairy colonies across the national capital recently, the city police and the Drug Control Department conducted a joint raid, busting an illegal manufacturing unit and arresting its owner, an official said on Sunday.

The accused was identified as Praveen Kumar, who indulged in the illegal manufacturing of veterinary oxytocin injections for the past six months without the requisite license.

“The premises were found stocked with various materials used in the manufacturing process, including empty plastic bottles, crimp caps, sealing machines, and raw materials for oxytocin preparation,” the official added.

The oxytocin veterinary injection is a restricted drug indicated for obstetrical use in cows, sheep, and horses. However, it is widely misused in milch animals to increase milk production, especially in dairies.

According to the Delhi government’s Drug Control Department, on Saturday, acting on the intelligence provided by the Station House Officer (SHO), Bhalswa Dairy police station, was tipped off about illegal manufacturing activities concerning oxytocin.

“A joint team of the Drug Control Department and the Delhi Police conducted a raid at the premises in Swaroop Nagar area and uncovered a clandestine operation of manufacturing oxytocin veterinary injection by the accused Praveen Kumar,” said a senior Drug Control Department official.

The accused also failed to produce any valid drug license or purchase records for the materials used in manufacturing.

“He (the accused) used to manufacture this preparation from a concentrated solution and manually fill in plastic bottles after dilution. These plastic bottles used to be manually sealed with the help of a crimping machine. It was also revealed that the illegal oxytocin was being supplied to various dairy farms without proper documentation. He used to get this oxytocin-concentrated solution from Ghaziabad in Uttar Pradesh as disclosed by him,” the official added.

In the course of the operation, samples of the illicitly manufactured oxytocin were collected for further testing/analysis as per the Drugs and Cosmetics Act,1940.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?